<DOC>
	<DOCNO>NCT00780013</DOCNO>
	<brief_summary>The objective study compare single-dose oral bioavailability metformin hydrochloride ( HCI ) liquid 500 mg/5 mL Ranbaxy GlucophageAÂ® 1000 mg tablet Bristol-Myers , USA follow administration 1000 mg dose healthy , adult , male female volunteer feed condition</brief_summary>
	<brief_title>Bioequivalence Study Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions</brief_title>
	<detailed_description>This open-label , balance , randomise , two-treatment , two-period , two-sequence , single-dose crossover bioavailability study perform 36 healthy adult male female non-smoking light smoke volunteer 2 alternate . A total 36 subject complete clinical phase study . In period , subject house even dose 24-hour blood draw . Single oral 1000 mg dos separate washout period 7 day Of 36 healthy adult non-smoking light-smoking ( 10 cigarettes/day ) volunteer 2 alternate ( 19 male , 19 non-pregnant female ) enrol study , two complete clinical phase study . Subject No . 11 withdrawn study on-duty Physician positive pregnancy test prior dose Period 2 Subject No . 20 withdrawn study Clinical Study Manager fail complete breakfast prior dose Period 2 . Thus total 36 subject complete clinical phase study</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Be age range 1845 year . 2 . Weigh least 60 kg male 52 kg female within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1953 ) . 3 . Have voluntarily give write informed consent participate study . 4 . Be medically healthy clinically normal laboratory profile determine medical history , physical examination laboratory test perform within 28 day prior commencement study . 5 . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior study throughout study use one follow acceptable birth control method : Surgically sterile ( tubal ligation , hysterectomy , bilateral oophorectomy ) 6 month minimum . Proof required hysterectomy oophorectomy ; IUD place least 3 month Barrier method spermicide ( condom , diaphragm ) least 14 day prior start study throughout study Surgical sterilization partner ( vasectomy 6 month minimum ) Hormonal contraceptive least 3 month prior start study . Other birth control method may deem acceptable . Postmenopausal woman amenorrhea least 2 year eligible.All female subject ask confirm compliance approve effective method birth control sign declaration form effect . 1 . History allergy metformin relate antidiabetic biguanide preparation . 2 . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination 3 . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , endrocrine , immunologic , dermatologic , neurological haematological 4. disease , diabetes glaucoma . 5 . History psychiatric illness may impair ability provide write informed consent . 6 . Regular smoker smoke 10 cigarette daily difficulty abstain smoke 1 hour dose 6 hour follow drug administration study period . 7 . Subjects problem drug alcohol abuse within past year difficulty abstain duration study period . 8 . Participation clinical trial within 28 day study start 9 . Subjects abnormal diet ( whatever reason ) 28 day precede first dosing . 10 . Females pregnant lactating . 11 . Subjects without adequate venous access leave right arm allow collection 38 blood sample via venipuncture 2 period . 12 . Subjects , completion study , would donate excess : 500 mL blood 14 day 500 750 mL blood 14 day ( unless approve Principal Investigator ) 1000 mL blood 90 day 1250 mL blood 120 day 1500 mL blood 180 day 2000 mL blood 270 day 2500 mL blood 1 year 13 ) Presence value significantly different normal reference range , judge physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence metformin hydrochloride</keyword>
</DOC>